16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stonesOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether gut microbiome composition differs in people with kidney stones (nephrolithiasis) compared to healthy people. Researchers used 16S ribosomal RNA (rRNA) gene sequencing to characterize the gut microbiota of both groups. They assessed diversity, overall community structure, and genus-level abundance differences, and examined correlations between specific bacterial genera and blood trace-element concentrations.
Who was studied?
The study included 13 patients with multiple kidney stones and 13 matched healthy controls. This is a small, case-control cohort rather than a large population sample. Matching between the two groups was used to help isolate microbiome differences associated with nephrolithiasis.
What were the most important findings?
Beta diversity analysis showed a clear separation in gut microbial community structure between nephrolithiasis patients and healthy controls. Twenty genera differed significantly in relative abundance between the two groups. Among these, Phascolarctobacterium, Parasutterella, Ruminiclostridium_5, Erysipelatoclostridium, Fusicatenibacter, and Dorea were correlated with blood concentrations of trace elements including potassium, sodium, calcium, and chlorinum. A decreasing trend in observed species richness was seen in patients, though it did not reach statistical significance (p = 0.086).
What are the greatest implications of this study?
These findings suggest a distinct gut microbiome signature is associated with nephrolithiasis and may link to blood trace-element balance. This raises the possibility that specific gut genera could serve as biomarkers or contribute mechanistically to kidney stone risk. Given the small sample size, larger studies are needed to confirm these associations and clarify causality.